Literature DB >> 30307408

CDCA7 and HELLS mutations undermine nonhomologous end joining in centromeric instability syndrome.

Motoko Unoki1, Hironori Funabiki2, Guillaume Velasco3, Claire Francastel3, Hiroyuki Sasaki1.   

Abstract

Mutations in CDCA7 and HELLS that respectively encode a CXXC-type zinc finger protein and an SNF2 family chromatin remodeler cause immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome types 3 and 4. Here, we demonstrate that the classical nonhomologous end joining (C-NHEJ) proteins Ku80 and Ku70, as well as HELLS, coimmunoprecipitated with CDCA7. The coimmunoprecipitation of the repair proteins was sensitive to nuclease treatment and an ICF3 mutation in CDCA7 that impairs its chromatin binding. The functional importance of these interactions was strongly suggested by the compromised C-NHEJ activity and significant delay in Ku80 accumulation at DNA damage sites in CDCA7- and HELLS-deficient HEK293 cells. Consistent with the repair defect, these cells displayed increased apoptosis, abnormal chromosome segregation, aneuploidy, centrosome amplification, and significant accumulation of γH2AX signals. Although less prominent, cells with mutations in the other ICF genes DNMT3B and ZBTB24 (responsible for ICF types 1 and 2, respectively) showed similar defects. Importantly, lymphoblastoid cells from ICF patients shared the same changes detected in the mutant HEK293 cells to varying degrees. Although the C-NHEJ defect alone did not cause CG hypomethylation, CDCA7 and HELLS are involved in maintaining CG methylation at centromeric and pericentromeric repeats. The defect in C-NHEJ may account for some common features of ICF cells, including centromeric instability, abnormal chromosome segregation, and apoptosis.

Entities:  

Keywords:  Cell Biology; Genetic instability; Genetics; Molecular pathology; Monogenic diseases

Mesh:

Substances:

Year:  2018        PMID: 30307408      PMCID: PMC6307953          DOI: 10.1172/JCI99751

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  71 in total

1.  SWI/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability.

Authors:  Reiko Watanabe; Ayako Ui; Shin-Ichiro Kanno; Hideaki Ogiwara; Takahiro Nagase; Takashi Kohno; Akira Yasui
Journal:  Cancer Res       Date:  2014-05-01       Impact factor: 12.701

Review 2.  Emerging therapeutic modalities of PARP inhibitors in breast cancer.

Authors:  Xin Wang; Yaqin Shi; Doudou Huang; Xiaoxiang Guan
Journal:  Cancer Treat Rev       Date:  2018-05-31       Impact factor: 12.111

3.  Three novel DNMT3B mutations in Japanese patients with ICF syndrome.

Authors:  Hisao Shirohzu; Takeo Kubota; Azumi Kumazawa; Takashi Sado; Takahito Chijiwa; Kouichi Inagaki; Isao Suetake; Shoji Tajima; Keiko Wakui; Yuko Miki; Masatoshi Hayashi; Yoshimitsu Fukushima; Hiroyuki Sasaki
Journal:  Am J Med Genet       Date:  2002-09-15

Review 4.  Chromatin remodeling at DNA double-strand breaks.

Authors:  Brendan D Price; Alan D D'Andrea
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

5.  An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome.

Authors:  M Jeanpierre; C Turleau; A Aurias; M Prieur; F Ledeist; A Fischer; E Viegas-Pequignot
Journal:  Hum Mol Genet       Date:  1993-06       Impact factor: 6.150

6.  Poly(ADP-ribosyl)ation links the chromatin remodeler SMARCA5/SNF2H to RNF168-dependent DNA damage signaling.

Authors:  Godelieve Smeenk; Wouter W Wiegant; Jurgen A Marteijn; Martijn S Luijsterburg; Nicholas Sroczynski; Thomas Costelloe; Ron J Romeijn; Albert Pastink; Niels Mailand; Wim Vermeulen; Haico van Attikum
Journal:  J Cell Sci       Date:  2012-12-21       Impact factor: 5.285

7.  Small RNAs Recruit Chromatin-Modifying Enzymes MMSET and Tip60 to Reconfigure Damaged DNA upon Double-Strand Break and Facilitate Repair.

Authors:  Qinhong Wang; Michael Goldstein
Journal:  Cancer Res       Date:  2016-01-28       Impact factor: 12.701

8.  QUMA: quantification tool for methylation analysis.

Authors:  Yuichi Kumaki; Masaaki Oda; Masaki Okano
Journal:  Nucleic Acids Res       Date:  2008-05-16       Impact factor: 16.971

9.  Germline genes hypomethylation and expression define a molecular signature in peripheral blood of ICF patients: implications for diagnosis and etiology.

Authors:  Guillaume Velasco; Emma L Walton; Delphine Sterlin; Sabrine Hédouin; Hirohisa Nitta; Yuya Ito; Fanny Fouyssac; André Mégarbané; Hiroyuki Sasaki; Capucine Picard; Claire Francastel
Journal:  Orphanet J Rare Dis       Date:  2014-04-17       Impact factor: 4.123

10.  ISWI chromatin remodeling complexes in the DNA damage response.

Authors:  Özge Z Aydin; Wim Vermeulen; Hannes Lans
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more
  25 in total

1.  Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC.

Authors:  Guoxin Zhang; Zhen Dong; Briana C Prager; Leo Jk Kim; Qiulian Wu; Ryan C Gimple; Xiuxing Wang; Shideng Bao; Petra Hamerlik; Jeremy N Rich
Journal:  JCI Insight       Date:  2019-04-04

Review 2.  Lymphoid-specific helicase in epigenetics, DNA repair and cancer.

Authors:  Xiangyu Chen; Yamei Li; Karla Rubio; Bi Deng; Yuyi Li; Qinwei Tang; Chao Mao; Shuang Liu; Desheng Xiao; Guillermo Barreto; Yongguang Tao
Journal:  Br J Cancer       Date:  2021-09-07       Impact factor: 9.075

3.  Diagnostic, Prognostic, and Immunological Roles of HELLS in Pan-Cancer: A Bioinformatics Analysis.

Authors:  Xiao Liang; Linji Li; Yuchao Fan
Journal:  Front Immunol       Date:  2022-06-14       Impact factor: 8.786

Review 4.  Seminars in cell and development biology on histone variants remodelers of H2A variants associated with heterochromatin.

Authors:  Frédéric Berger; Kathrin Muegge; Eric J Richards
Journal:  Semin Cell Dev Biol       Date:  2022-03-03       Impact factor: 7.499

5.  The chromatin remodelling protein LSH/HELLS regulates the amount and distribution of DNA hydroxymethylation in the genome.

Authors:  Maud De Dieuleveult; Martin Bizet; Laurence Colin; Emilie Calonne; Martin Bachman; Chao Li; Irina Stancheva; Benoit Miotto; François Fuks; Rachel Deplus
Journal:  Epigenetics       Date:  2021-05-07       Impact factor: 4.528

6.  Lsh/HELLS is required for B lymphocyte development and immunoglobulin class switch recombination.

Authors:  Yafeng He; Jianke Ren; Xiaoping Xu; Kai Ni; Andrew Schwader; Richard Finney; Can Wang; Lei Sun; Kimberly Klarmann; Jonathan Keller; Anthony Tubbs; Andre Nussenzweig; Kathrin Muegge
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-29       Impact factor: 11.205

Review 7.  Keeping the Centromere under Control: A Promising Role for DNA Methylation.

Authors:  Andrea Scelfo; Daniele Fachinetti
Journal:  Cells       Date:  2019-08-16       Impact factor: 6.600

8.  The epigenetic regulator LSH maintains fork protection and genomic stability via MacroH2A deposition and RAD51 filament formation.

Authors:  Xiaoping Xu; Kai Ni; Yafeng He; Jianke Ren; Chongkui Sun; Yie Liu; Mirit I Aladjem; Sandra Burkett; Richard Finney; Xia Ding; Shyam K Sharan; Kathrin Muegge
Journal:  Nat Commun       Date:  2021-06-10       Impact factor: 14.919

9.  Identification of endometriosis-associated genes and pathways based on bioinformatic analysis.

Authors:  Ting Wang; Ruoan Jiang; Yingsha Yao; Linhua Qian; Yu Zhao; Xiufeng Huang
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

Review 10.  Centromeres under Pressure: Evolutionary Innovation in Conflict with Conserved Function.

Authors:  Elisa Balzano; Simona Giunta
Journal:  Genes (Basel)       Date:  2020-08-10       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.